抗体与药物联合剂:原则和机遇
Zhi Xin Phuna1, Prashanth Ashok Kumar2, Elio Haroun2
1Research and Development, Medicovestor, Inc, New York City, NY, United States of America.
Life sciences
|April 30, 2024
概括
抗体-药物合物 (ADC) 通过将抗体与细胞毒剂结合起来,提供向癌症治疗. 这种方法旨在增强瘤细胞的杀死,同时最大限度地减少化疗副作用.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗体-药物合物 (ADCs) 是癌症治疗的一类有前途的药物.
- ADCs利用单克隆抗体对瘤细胞有针对性地传递强大的细胞毒性有效载荷.
- 这种有针对性的方法旨在提高疗效和减少与传统化疗相比的全身毒性.
研究的目的:
- 提供对抗体特异性和ADC结构的概述.
- 讨论ADC的作用机制和耐药性发展.
- 探索增强ADC有效性和克服耐药性的策略.
主要方法:
- 文献综述和对ADCs当前研究的综合.
- 分析ADC机制,耐药性途径和治疗进展.
- 探索癌症治疗ADC开发的未来前景.
主要成果:
- ADCs将抗体特异性与细胞毒性有效载荷相结合,用于向瘤细胞杀死.
- 目标识别,有效载荷和链接器方面的进展扩大了ADC的治疗潜力.
- 了解耐药机制对于优化ADC疗效至关重要.
结论:
- 抗癌药提供了一种有针对性的方法来治疗癌症,并减少副作用.
- 对新型目标,有效载荷和克服耐药性的持续研究对于推进ADC治疗至关重要.
- 抗癌药物在改善癌症治疗结果方面具有显著的希望.
更多相关视频
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
7.6K
09:39Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF
Published on: September 17, 2019
6.9K
相关概念视频
Phase II Conjugation Reactions: Overview
189
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
189
Antibody Actions
1.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.1K
Principles of Drug Action
6.0K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.0K
Prodrugs
2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.6K
Drug Metabolism: Phase II Reactions
3.8K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.8K
Antibody Structure
60.1K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
60.1K
